Genmab Ownership | Who Owns Genmab?

Overview Forecast RevenueFinancials Chart Transcripts

Genmab Ownership Summary

Genmab is owned by 55.22% institutional investors, 0.03% insiders, and 44.76% retail investors. Alliancebernstein is the largest institutional shareholder, holding 23.02% of GMAB shares. AllianceBernstein US L/C Growth Eqty MF is the top mutual fund, with 0.90% of its assets in Genmab shares.

GMAB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Genmab	55.22%	0.03%	44.76%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Alliancebernstein	14.94M	23.02%	$311.70M
Blackrock	5.08M	7.78%	$127.67M
Blackrock funding, inc. /de	4.20M	6.47%	$87.62M
Orbis allan gray	2.82M	4.34%	$58.76M
Capital investors	2.57M	3.96%	$53.40M
Harding loevner lp	2.24M	3.46%	$46.82M
Deep track capital, lp	2.00M	3.08%	$41.74B
Renaissance	1.93M	2.97%	$40.20M
Two sigma investments, lp	1.71M	2.63%	$35.61M
Two sigma advisers, lp	1.65M	2.55%	$34.51M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bridger management	291.50K	3.27%	$6.08M
Deep track capital, lp	2.00M	1.56%	$41.74B
Aimz investment advisors	168.91K	1.22%	$3.53M
Ddd partners	226.07K	0.58%	$4.72M
Harding loevner lp	2.24M	0.32%	$46.82M
Orbis allan gray	2.82M	0.32%	$58.76M
Brandywine global investment management	1.62M	0.25%	$33.80M
Legacy wealth asset management	36.12K	0.21%	$753.85K
Penderfund capital management	31.10K	0.20%	$932.99K
Hardman johnston global advisors	214.47K	0.18%	$4.48M

Top Buyers

Holder	Shares	% Assets	Change
Deep track capital, lp	2.00M	1.56%	2.00M
Brandywine global investment management	1.62M	0.25%	1.62M
Ubs group	1.44M	0.01%	1.38M
Orbis allan gray	2.82M	0.32%	1.14M
Two sigma advisers, lp	1.65M	0.08%	1.04M

Top Sellers

Holder	Shares	% Assets	Change
Wellington management group llp	-	-	-2.31M
Capital investors	2.57M	0.01%	-1.85M
Harding loevner lp	2.24M	0.32%	-823.55K
Royal bank of canada	324.00K	0.00%	-473.81K
Blackrock funding, inc. /de	4.20M	0.00%	-418.51K

New Positions

Holder	Shares	% Assets	Change	Value
Deep track capital, lp	2.00M	1.56%	2.00M	$41.74B
Brandywine global investment management	1.62M	0.25%	1.62M	$33.80M
Bridger management	291.50K	3.27%	291.50K	$6.08M
Aimz investment advisors	168.91K	1.22%	168.91K	$3.53M
Bnp paribas arbitrage, snc	122.37K	0.00%	122.37K	$2.55M

Sold Out

Holder	Change
Zurcher kantonalbank (zurich cantonalbank)	-1.00
Central trust	-7.00
Clarivest asset management	-13.00
Zions bancorporation, n.a.	-18.00
Lynx investment advisory	-21.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	154	-31.56%	35,827,984	-31.48%	55	0.85%	73	-42.52%	59	-9.23%
Sep 30, 2024	224	1.36%	52,289,656	7.32%	80	1.43%	126	32.63%	65	-29.35%
Jun 30, 2024	218	-5.63%	48,717,902	1.76%	74	1.39%	94	-27.69%	90	25.00%
Mar 31, 2024	231	2.21%	47,874,180	2.68%	73	143.77%	130	32.65%	72	-28.71%
Dec 31, 2023	226	-3.83%	46,625,289	-1.67%	7	13.52%	98	-28.99%	101	80.36%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
AllianceBernstein US L/C Growth Eqty MF	5.68M	0.90%	-
AB Large Cap Growth A	4.22M	0.67%	-85.69K
iShares Biotechnology ETF	2.95M	0.46%	-37.66K
Vanguard Health Care Inv	2.29M	0.36%	-
T. Rowe Price International Gr Eq SMA	1.90M	0.30%	1.90M
First Trust NYSE Arca Biotech ETF	1.69M	0.27%	-
American Growth One D	1.24M	0.20%	-
AB American Growth AX USD	1.24M	0.20%	-
AB US Large Cap Growth CT B	1.23M	0.19%	-143.50K
Xtrackers S&P 500 Swap ETF 1C	1.02M	0.16%	1.02M

GMAB Ownership FAQ

Who Owns Genmab?

Genmab shareholders are primarily institutional investors at 55.22%, followed by 0.03% insiders and 44.75% retail investors. The average institutional ownership in Genmab's industry, Biotech Stocks , is 68.48%, which Genmab falls below.

Who owns the most shares of Genmab?

Genmab’s largest shareholders are Alliancebernstein (14.94M shares, 23.02%), Blackrock (5.08M shares, 7.78%), and Blackrock funding, inc. /de (4.2M shares, 6.47%). Together, they hold 37.27% of Genmab’s total shares outstanding.

Does Blackrock own Genmab?

Yes, BlackRock owns 7.78% of Genmab, totaling 5.08M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 127.67M$. In the last quarter, BlackRock increased its holdings by 13.43K shares, a 0.27% change.

Who is Genmab’s biggest shareholder by percentage of total assets invested?

Bridger management is Genmab’s biggest shareholder by percentage of total assets invested, with 3.27% of its assets in 291.5K Genmab shares, valued at 6.08M$.

Who is the top mutual fund holder of Genmab shares?

AllianceBernstein US L/C Growth Eqty MF is the top mutual fund holder of Genmab shares, with 0.90% of its total shares outstanding invested in 5.68M Genmab shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools